Bone health depends on a complex interplay of hormones, nutrition, and environmental factors. PFAS have been identified as potential disruptors of bone metabolism, with research suggesting associations between PFAS exposure and reduced bone mineral density — a key risk factor for osteoporosis and fracture.
PFAS Effects on Bone Mineral Density
Bone mineral density (BMD) is the primary measure of bone strength and fracture risk. Multiple epidemiological studies have found inverse associations between serum PFAS levels and BMD at various skeletal sites, including the hip, spine, and total body. These associations have been observed in postmenopausal women — who are at highest osteoporosis risk — as well as in men and premenopausal women.
A large study using NHANES data found that higher PFAS concentrations were associated with significantly lower BMD at multiple skeletal sites, with the associations strongest for PFOA, PFOS, and PFHxS. The magnitude of BMD reduction associated with PFAS exposure was clinically meaningful and comparable to the effects of established osteoporosis risk factors.
Mechanisms of PFAS Bone Toxicity
Several mechanisms may explain how PFAS affect bone metabolism. PFAS disrupt sex hormone signaling — estrogens and androgens are critical for maintaining bone density, and PFAS interference with these hormones could impair bone maintenance. PFAS also affect thyroid hormones, which regulate bone turnover and osteoblast activity.
PFAS may directly affect osteoblasts (bone-building cells) and osteoclasts (bone-resorbing cells), altering the balance between bone formation and resorption. Additionally, PFAS can compete with calcium for binding sites, potentially reducing the availability of calcium for bone mineralization.
Children and Adolescent Bone Development
Peak bone mass is established during childhood and adolescence, making these developmental periods critical for lifetime bone health. Research has examined PFAS effects on bone accrual in children, with some studies finding lower BMD and altered bone geometry in children with higher PFAS exposures.
If PFAS reduce peak bone mass during childhood, the consequences could persist throughout adulthood and increase fracture risk in later life — representing a lifetime consequence of childhood exposure that may not manifest clinically for decades.
Fracture Risk
Some studies have moved beyond BMD measurement to examine actual fracture rates in relation to PFAS exposure. A study of older adults found that higher PFAS blood levels were associated with increased likelihood of fracture history, consistent with the hypothesis that PFAS-associated BMD reductions translate into clinically meaningful fracture risk increases.
Protecting Bone Health
For postmenopausal women, older adults, and individuals with osteoporosis risk factors, reducing PFAS exposure represents a modifiable environmental risk factor for bone health. Combined with adequate calcium and vitamin D intake, weight-bearing exercise, and appropriate medical management, water filtration provides an additional layer of bone protection by reducing PFAS intake from drinking water.